Related Experiment Video
Updated: Jun 14, 2026

On-chip Isotachophoresis for Separation of Ions and Purification of Nucleic Acids
Published on: March 2, 2012
Future research in ITP: an ICIS consensus
James L Zehnder1, John W Semple, Paul Imbach
1Department of Pathology, Stanford University School of Medicine, L235, Stanford, CA, 94305, USA, zehnder@stanford.edu.
While much has been learned about the basic immunology and clinical characteristics of immune thrombocytopenia, many important questions remain with regard to pathogenesis, disease progression, identification of novel therapeutic targets and approaches, and clinical trials that rationalize and optimize use of existing therapies. The answers to these questions are likely to impact our understanding of the pathogenesis and therapeutic targets of autoimmune disease in general.
While much has been learned about the basic immunology and clinical characteristics of immune thrombocytopenia, many important questions remain with regard to pathogenesis, disease progression, identification of novel therapeutic targets and approaches, and clinical trials that rationalize and optimize use of existing therapies. The answers to these questions are likely to impact our understanding of the pathogenesis and therapeutic targets of autoimmune disease in general.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
EPS and iPS Cells in Disease Research
Ion-Exchange Chromatography
Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview
Interpersonal Psychotherapy
Induced Pluripotent Stem Cells